메뉴 건너뛰기




Volumn 11, Issue 4, 2011, Pages 300-306

Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: From retrospective to prospective

Author keywords

diltiazem; drug drug interaction; prospective study; tacrolimus; YP3A5

Indexed keywords

CYTOCHROME P450 3A5; DILTIAZEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

EID: 79960634582     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2010.42     Document Type: Article
Times cited : (52)

References (37)
  • 2
    • 3242772986 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
    • DOI 10.2165/00003088-200443100-00001
    • Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004; 43: 623-653. (Pubitemid 38981845)
    • (2004) Clinical Pharmacokinetics , vol.43 , Issue.10 , pp. 623-653
    • Staatz, C.E.1    Tett, S.E.2
  • 4
    • 0033032643 scopus 로고    scopus 로고
    • Diltiazem increases tacrolimus concentrations
    • DOI 10.1345/aph.18356
    • Hebert MF, Lam AY. Diltiazem increases tacrolimus concentrations. Ann Pharmacother 1999; 33: 680-682. (Pubitemid 29309723)
    • (1999) Annals of Pharmacotherapy , vol.33 , Issue.6 , pp. 680-682
    • Hebert, M.F.1    Lam, A.Y.2
  • 5
    • 0036290197 scopus 로고    scopus 로고
    • Pharmacokinetic interaction between tacrolimus and diltiazem: Dose-response relationship in kidney and liver transplant recipients
    • Jones TE, Morris RG. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients. Clin Pharmacokinet 2002; 41: 381-388. (Pubitemid 34713091)
    • (2002) Clinical Pharmacokinetics , vol.41 , Issue.5 , pp. 381-388
    • Jones, T.E.1    Morris, R.G.2
  • 6
    • 53549126614 scopus 로고    scopus 로고
    • Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients
    • Kuypers DR, de Jonge H, Naesens M, Vanrenterghem Y. Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients. Pharmacogenet Genomics 2008; 18: 861-868.
    • (2008) Pharmacogenet Genomics , vol.18 , pp. 861-868
    • Kuypers, D.R.1    De Jonge, H.2    Naesens, M.3    Vanrenterghem, Y.4
  • 7
    • 56149107690 scopus 로고    scopus 로고
    • Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism
    • Kalliokoski A, Backman JT, Kurkinen KJ, Neuvonen PJ, Niemi M. Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. Clin Pharmacol Ther 2008; 84: 488-496.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 488-496
    • Kalliokoski, A.1    Backman, J.T.2    Kurkinen, K.J.3    Neuvonen, P.J.4    Niemi, M.5
  • 8
    • 33644908781 scopus 로고    scopus 로고
    • Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status
    • DOI 10.1111/j.1365-2125.2005.02556.x
    • Uno T, Shimizu M, Yasui-Furukori N, Sugawara K, Tateishi T. Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. Br J Clin Pharmacol 2006; 61: 309-314. (Pubitemid 43382630)
    • (2006) British Journal of Clinical Pharmacology , vol.61 , Issue.3 , pp. 309-314
    • Uno, T.1    Shimizu, M.2    Yasui-Furukori, N.3    Sugawara, K.4    Tateishi, T.5
  • 9
    • 55149095948 scopus 로고    scopus 로고
    • Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects
    • Lim KS, Cho JY, Jang IJ, Kim BH, Kim J, Jeon JY et al. Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects. Br J Clin Pharmacol 2008; 66: 660-666.
    • (2008) Br J Clin Pharmacol , vol.66 , pp. 660-666
    • Lim, K.S.1    Cho, J.Y.2    Jang, I.J.3    Kim, B.H.4    Kim, J.5    Jeon, J.Y.6
  • 11
    • 70149105801 scopus 로고    scopus 로고
    • CYP3A5*1/*3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazole
    • Chandel N, Aggarwal PK, Minz M, Sakhuja V, Kohli KK, Jha V. CYP3A5*1/*3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazole. Pharmacogenet Genomics 2009; 19: 458-463.
    • (2009) Pharmacogenet Genomics , vol.19 , pp. 458-463
    • Chandel, N.1    Aggarwal, P.K.2    Minz, M.3    Sakhuja, V.4    Kohli, K.K.5    Jha, V.6
  • 15
    • 0027167470 scopus 로고
    • Inhibition by paroxetine and desipramine metabolism in extensive but not in poor metabolizers of sparteine
    • DOI 10.1007/BF00316471
    • Brosen K, Hansen JG, Nielsen KK, Sindrup SH, Gram LF. Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine. Eur J Clin Pharmacol 1993; 44: 349-355. (Pubitemid 23153452)
    • (1993) European Journal of Clinical Pharmacology , vol.44 , Issue.4 , pp. 349-355
    • Brosen, K.1    Hansen, J.G.2    Nielsen, K.K.3    Sindrup, S.H.4    Gram, L.F.5
  • 16
    • 0032847231 scopus 로고    scopus 로고
    • Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans
    • Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeon J. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Pharmacogenetics 1999; 9: 435-443. (Pubitemid 29419562)
    • (1999) Pharmacogenetics , vol.9 , Issue.4 , pp. 435-443
    • Lessard, E.1    Yessine, M.-A.2    Hamelin, B.A.3    O'Hara, G.4    LeBlanc, J.5    Turgeon, J.6
  • 18
    • 42749089907 scopus 로고    scopus 로고
    • Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: Application to a clinical drug-drug interaction study
    • Li JL, Wang XD, Wang CX, Fu Q, Liu LS, Huang M et al. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 867: 111-118.
    • (2008) J Chromatogr B Analyt Technol Biomed Life Sci , vol.867 , pp. 111-118
    • Li, J.L.1    Wang, X.D.2    Wang, C.X.3    Fu, Q.4    Liu, L.S.5    Huang, M.6
  • 19
    • 0025779048 scopus 로고
    • An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents
    • Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A. An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods 1991; 34: 105-112.
    • (1991) J Virol Methods , vol.34 , pp. 105-112
    • Loparev, V.N.1    Cartas, M.A.2    Monken, C.E.3    Velpandi, A.4    Srinivasan, A.5
  • 20
    • 60549093838 scopus 로고    scopus 로고
    • Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem
    • Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X et al. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem. Eur J Clin Pharmacol 2009; 65: 239-247.
    • (2009) Eur J Clin Pharmacol , vol.65 , pp. 239-247
    • Wang, Y.1    Wang, C.2    Li, J.3    Wang, X.4    Zhu, G.5    Chen, X.6
  • 25
    • 45449099489 scopus 로고    scopus 로고
    • Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients
    • DOI 10.1016/j.transproceed.2008.04.010, PII S0041134508004284
    • Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients. Transplant Proc 2008; 40: 1690-1695. (Pubitemid 351853194)
    • (2008) Transplantation Proceedings , vol.40 , Issue.5 , pp. 1690-1695
    • Loh, P.T.1    Lou, H.X.2    Zhao, Y.3    Chin, Y.M.4    Vathsala, A.5
  • 27
    • 0026681546 scopus 로고
    • Functional and morphological changes in rat kidney induced by FK506 and its reversal by various vasodilators
    • Kumano K, Endo T, Koshiba K. [Functional and morphological changes in rat kidney induced by FK506 and its reversal by various vasodilators]. Nippon Hinyokika Gakkai Zasshi 1992; 83: 650-657.
    • (1992) Nippon Hinyokika Gakkai Zasshi , vol.83 , pp. 650-657
    • Kumano, K.1    Endo, T.2    Koshiba, K.3
  • 28
    • 0028916159 scopus 로고
    • Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs
    • Bensoussan C, Delaforge M, Mansuy D. Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Biochem Pharmacol 1995; 49: 591-602.
    • (1995) Biochem Pharmacol , vol.49 , pp. 591-602
    • Bensoussan, C.1    Delaforge, M.2    Mansuy, D.3
  • 29
    • 4644263308 scopus 로고    scopus 로고
    • CYP3A5 contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects
    • Yamaori S, Yamazaki H, Iwano S, Kiyotani K, Matsumura K, Honda G et al. CYP3A5 contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects. Drug Metab Pharmacokinet 2004; 19: 120-129.
    • (2004) Drug Metab Pharmacokinet , vol.19 , pp. 120-129
    • Yamaori, S.1    Yamazaki, H.2    Iwano, S.3    Kiyotani, K.4    Matsumura, K.5    Honda, G.6
  • 30
    • 31344466713 scopus 로고    scopus 로고
    • Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients
    • Uesugi M, Masuda S, Katsura T, Oike F, Takada Y, Inui K. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in livingdonor liver transplant recipients. Pharmacogenet Genomics 2006; 16: 119-127. (Pubitemid 43145680)
    • (2006) Pharmacogenetics and Genomics , vol.16 , Issue.2 , pp. 119-127
    • Uesugi, M.1    Masuda, S.2    Katsura, T.3    Oike, F.4    Takada, Y.5    Inui, K.-I.6
  • 33
    • 1542376174 scopus 로고    scopus 로고
    • Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: A comparative analysis in paired tissue specimens
    • DOI 10.1016/j.clpt.2003.10.008, PII S0009923603007288
    • Von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, Kivisto KT. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 2004; 75: 172-183. (Pubitemid 38314866)
    • (2004) Clinical Pharmacology and Therapeutics , vol.75 , Issue.3 , pp. 172-183
    • Von Richter, O.1    Burk, O.2    Fromm, M.F.3    Thon, K.P.4    Eichelbaum, M.5    Kivisto, K.T.6
  • 34
    • 0038000046 scopus 로고    scopus 로고
    • The nuclear pregnane X receptor regulates xenobiotic detoxification
    • Kliewer SA. The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr 2003; 133: 2444S-2447S. (Pubitemid 36828852)
    • (2003) Journal of Nutrition , vol.133 , Issue.7 SUPPL.
    • Kliewer, S.A.1
  • 36
    • 37549010733 scopus 로고    scopus 로고
    • Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression
    • Lamba J, Lamba V, Strom S, Venkataramanan R, Schuetz E. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 2008; 36: 169-181.
    • (2008) Drug Metab Dispos , vol.36 , pp. 169-181
    • Lamba, J.1    Lamba, V.2    Strom, S.3    Venkataramanan, R.4    Schuetz, E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.